Literature DB >> 7953643

State dependency of the effects of microinjection of cholinergic drugs into the nucleus pontis oralis.

F López-Rodríguez1, K Kohlmeier, F R Morales, M H Chase.   

Abstract

The microinjection of cholinergic drugs into the pontine reticular formation elicits active sleep-like states that are comprised of the principal physiological patterns of activity that characterize naturally-occurring active sleep, i.e., EEG desynchronization, PGO waves, rapid eye movements and atonia. We have reported that other behavioral states arise even when cholinergic drugs are injected into the exact same reticular location. The present study was conducted to explore the basis for the differences in the drug effect. A combination of acetylcholine and neostigmine was injected by microiontophoresis into the dorsal region of the nucleus pontis oralis in four chronic, unanesthetized cats. The states that were induced by cholinergic drug injection depended on the state of the animal at the time of the injection. When the animal was awake, cholinergic injections resulted in a waking-dissociated state, which was characterized by EEG desynchronization and muscle atonia in a cat that appeared to be awake and was able to track objects in its visual field. If the cat was in quiet sleep at the time of the injection, an active sleep-like state followed that was indistinguishable from naturally-occurring active sleep; on a few occasions following cholinergic injections during quiet sleep there was a quiet sleep-dissociated state, which was characterized by PGO waves and muscle atonia in the cat that by other indices appeared to be in quiet sleep. The results of this study indicate that the state of the animal at the time of drug injection is a critical variable that influences the responses which are induced by cholinergic stimulation of the pontine reticular formation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7953643     DOI: 10.1016/0006-8993(94)91074-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Eye movements and abducens motoneuron behavior during cholinergically induced REM sleep.

Authors:  Javier Márquez-Ruiz; Miguel Escudero
Journal:  Sleep       Date:  2009-04       Impact factor: 5.849

2.  A restricted parabrachial pontine region is active during non-rapid eye movement sleep.

Authors:  P Torterolo; S Sampogna; M H Chase
Journal:  Neuroscience       Date:  2011-06-15       Impact factor: 3.590

3.  MCH-containing neurons in the hypothalamus of the cat: searching for a role in the control of sleep and wakefulness.

Authors:  Pablo Torterolo; Sharon Sampogna; Francisco R Morales; Michael H Chase
Journal:  Brain Res       Date:  2006-10-09       Impact factor: 3.252

4.  c-fos expression in brainstem premotor interneurons during cholinergically induced active sleep in the cat.

Authors:  F R Morales; S Sampogna; J Yamuy; M H Chase
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

Review 5.  Pontine reticular formation (PnO) administration of hypocretin-1 increases PnO GABA levels and wakefulness.

Authors:  Christopher J Watson; Haideliza Soto-Calderon; Ralph Lydic; Helen A Baghdoyan
Journal:  Sleep       Date:  2008-04       Impact factor: 5.849

6.  Restoring Conscious Arousal During Focal Limbic Seizures with Deep Brain Stimulation.

Authors:  Adam J Kundishora; Abhijeet Gummadavelli; Chanthia Ma; Mengran Liu; Cian McCafferty; Nicholas D Schiff; Jon T Willie; Robert E Gross; Jason Gerrard; Hal Blumenfeld
Journal:  Cereb Cortex       Date:  2017-03-01       Impact factor: 5.357

7.  Hypocretinergic and non-hypocretinergic projections from the hypothalamus to the REM sleep executive area of the pons.

Authors:  Pablo Torterolo; Sharon Sampogna; Michael H Chase
Journal:  Brain Res       Date:  2012-10-30       Impact factor: 3.252

Review 8.  Evaluating the Evidence Surrounding Pontine Cholinergic Involvement in REM Sleep Generation.

Authors:  Kevin P Grace; Richard L Horner
Journal:  Front Neurol       Date:  2015-09-01       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.